Verve Revenue and Competitors

London, UK

Location

$4.3M

Total Funding

Salestech

Industry

Estimated Revenue & Valuation

  • Verve's estimated annual revenue is currently $1.7M per year.(i)
  • Verve received $10.0M in venture funding in October 2016.
  • Verve's estimated revenue per employee is $98,824
  • Verve's total funding is $4.3M.

Employee Data

  • Verve has 17 Employees.(i)
  • Verve grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7539.7M414270%N/AN/A
#2
$297.2M146413%N/AN/A
Add Company

Verve is the global market leader in word-of-mouth sales in the live entertainment and travel industry. We use networks of advocates to sell products and experiences to their friends in exchange for rewards such as free tickets and backstage passes. We do this in two ways: - Verve is a software product that enables live entertainment and travel brands to turn their most influential customers into ambassadors. - Pollen is a global marketplace housing a network of the most influential young people who bring their friends to curated experiences they are passionate about. Our technology powers over 500 music, travel, hotel and sports brands in 40 countries with more than 25,000 active advocates. We also have global partnerships with ticketing companies including Ticketmaster, Eventbrite, Paylogic and Front Gate Tickets.

keywords:saas, Entertainment,Music

$4.3M

Total Funding

17

Number of Employees

$1.7M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Verve News

2022-04-20 - Verve Signs ‘Alleluia’ Belgian Filmmaker Fabrice du Welz

Verve Signs 'Alleluia' Belgian Filmmaker Fabrice du Welz. Anthony D'Alessandro. Fri, April 22, 2022, 1:35 PM ·1 min read. In this article: Fabrice Du Welz.

2022-04-20 - Verve Signs ‘Alleluia’ Belgian Filmmaker Fabrice du Welz

Verve Signs 'Alleluia' Belgian Filmmaker Fabrice du Welz. Anthony D'Alessandro. Fri, April 22, 2022, 1:35 PM ·1 min read. In this article: Fabrice Du Welz.

2022-04-19 - Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks ...

Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks Investment Research to “Sell”. Posted by admin on Apr 22nd, 2022.

2022-04-19 - Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks ...

Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks Investment Research to “Sell”. Posted by admin on Apr 22nd, 2022.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M17N/A$8M
#2
$1.8M17-39%N/A
#3
$0.9M1721%N/A
#4
$1.5M170%N/A
#5
$2.5M1713%N/A

Verve Funding

DateAmountRoundLead InvestorsReference
2016-10-11$10.0MUndisclosedKindred CapitalArticle